Cytokinetics Announces Opening of Third and Final Cohort in ATOMIC-AHF Reuters Independent Data Monitoring Committee Recommends Progression in Ongoing Phase IIb Clinical Trial of Intravenous Form of Omecamtiv Mecarbil in Patients with Acute Heart Failure. South San Francisco, CA, November 29, 2012 - Cytokinetics, Incorporated ... |
